{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:27:08Z","timestamp":1787045228278,"version":"build-2736575974"},"reference-count":62,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"unspecified","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjpo"],"accepted":{"date-parts":[[2026,7,28]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medication-related harm in children is a major global public health concern, with adverse drug reactions (ADRs) contributing substantially to morbidity and healthcare costs. This study aimed to estimate ADR incidence, identify determinants of polypharmacy, examine its association with ADR risk and assess the clinical and economic impact of ADRs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multicentre prospective cohort study with a nested case\u2013control component was conducted among paediatric inpatients in four comprehensive specialised hospitals in Northwest Ethiopia. Cox proportional hazards regression identified predictors of ADR occurrence, and logistic regression assessed determinants of polypharmacy. For the nested case\u2013control analysis, categorical outcomes were compared using the McNemar test, while continuous outcomes were compared using a generalised linear model. Statistical significance was set at p&lt;0.05 with 95% CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1247 paediatric inpatients, 320 (25.7%) experienced at least one ADR, totalling 347 events (22.5 per 1000 patient-days). Independent predictors of ADRs included off-label drug use (adjusted HR (AHR) 1.3, 95%\u2009CI 1.0 to 1.6), immunocompromised status (AHR 1.6, 95%\u2009CI 1.2 to 1.9), three disease conditions (AHR 1.4, 95% CI 1.0 to 1.9), four or more disease conditions (AHR 1.9, 95%\u2009CI 1.2 to 2.4), systemic anti-infective use (AHR 1.4, 95%\u2009CI 1.1 to 1.8) and excessive polypharmacy (AHR 1.4, 95%\u2009CI 1.0 to 1.9). Polypharmacy (\u22655 medications) was observed in 56.7% of patients and was associated with multiple prescribers (AOR 1.48, 95%\u2009CI 1.1 to 2.0), hospital stay \u226514 days (AOR 1.60, 95%\u2009CI 1.1 to 2.6), each additional antibiotic (AOR 2.5, 95%\u2009CI 2.2 to 2.9) and each additional intravenous medication (AOR 2.6, 95%\u2009CI 2.1 to 3.0). ADR cases had longer hospital stays (15.7\u00b15.6 vs 12.2\u00b13.0\u2009days; \u03b2=0.213, 95%\u2009CI 0.171 to 0.256)\u2009and higher medical costs (6027\u00b11037.6 vs 4483.8\u00b1703.9\u2009Ethiopian birr; \u03b2=0.296, 95%\u2009CI 0.270 to 0.322) than controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ADRs are common among hospitalised children in Northwest Ethiopia and are associated with prolonged hospital stay and increased healthcare costs. Polypharmacy is also highly prevalent, driven by the complexity of care, and independently increases the risk of ADRs. Strengthening pharmacovigilance and promoting rational prescribing with targeted monitoring of high-risk children may help to reduce medication-related harm and economic burden in paediatric patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjpo-2026-004745","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:40:17Z","timestamp":1787042417000},"page":"e004745","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Polypharmacy and adverse drug reactions among hospitalised children: determinants and clinical and economic impact in a multicentre prospective cohort and nested matched case\u2013control study in Northwest Ethiopia"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3431-8187","authenticated-orcid":false,"given":"Abel Temeche","family":"Kassaw","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0723-6804","authenticated-orcid":false,"given":"Samuel Agegnew","family":"Wondm","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desalegn Addis","family":"Mussie","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getachew Yitayew","family":"Tarekegn","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigabu Eskeziya","family":"Zerihun","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6813-8792","authenticated-orcid":false,"given":"Tilaye Arega","family":"Moges","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-4014","authenticated-orcid":false,"given":"Woretaw Sisay","family":"Zewdu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Pharmacy Education and Clinical Service Directorate, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias Alemayehu","family":"Beriso","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Institute of Health, Bule Hora University, Bule Hora, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fasil Bayafers","family":"Tamene","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teferi Bihonegn","family":"Melese","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Berihun","family":"Dagnew","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"2026081801401018000_10.1.e004745.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024061","article-title":"Adverse drug reactions in children--a systematic review","volume":"7","author":"Smyth","year":"2012","journal-title":"PLoS One"},{"key":"2026081801401018000_10.1.e004745.2","first-page":"4","article-title":"Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety","volume":"24","author":"Rieder","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2026081801401018000_10.1.e004745.3","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01407.x"},{"key":"2026081801401018000_10.1.e004745.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-013-1563-z"},{"key":"2026081801401018000_10.1.e004745.5","doi-asserted-by":"crossref","DOI":"10.3389\/frhs.2025.1741402","article-title":"Active monitoring vs. spontaneous reporting of antineoplastic drug-related adverse drug reactions: evidence from the Chinese hospital pharmacovigilance system","volume":"5","author":"Jing","year":"2025","journal-title":"Front Health Serv"},{"key":"2026081801401018000_10.1.e004745.6","doi-asserted-by":"crossref","unstructured":"Khot A , Dakhale G . Perspective chapter: challenges and possible solutions of ADR monitoring (Pharmacovigilance) in low- and middle-income countries. In: Badria F , ed. Pharmacovigilance - facts, challenges, limitations and opportunities. London: IntechOpen, 2024.","DOI":"10.5772\/intechopen.1006043"},{"key":"2026081801401018000_10.1.e004745.7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/tropej\/fmy067","article-title":"Adverse Drug Reactions in Paediatric In-Patients in a South African Tertiary Hospital","volume":"65","author":"Makiwane","year":"2019","journal-title":"J Trop Pediatr"},{"key":"2026081801401018000_10.1.e004745.8","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.152629"},{"key":"2026081801401018000_10.1.e004745.9","doi-asserted-by":"crossref","first-page":"20420986261422800","DOI":"10.1177\/20420986261422800","article-title":"The magnitude of drug-related problems, typology, and predictors among patients admitted to the pediatric intensive care unit: impact of pharmacist-led interventions in Northwest Ethiopia","volume":"17","author":"Kassaw","year":"2026","journal-title":"Ther Adv Drug Saf"},{"key":"2026081801401018000_10.1.e004745.10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/2042098617702615","article-title":"Risk factors for adverse drug reactions in pediatric inpatients: a systematic review","volume":"8","author":"Andrade","year":"2017","journal-title":"Ther Adv Drug Saf"},{"key":"2026081801401018000_10.1.e004745.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-011-1183-4"},{"key":"2026081801401018000_10.1.e004745.12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s11096-021-01249-8","article-title":"Causality and avoidability of adverse drug reactions of antibiotics in hospitalized children: a cohort study","volume":"43","author":"Ramos","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"2026081801401018000_10.1.e004745.13","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00228-012-1302-x","article-title":"Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia","volume":"68","author":"Rashed","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"2026081801401018000_10.1.e004745.14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00228-022-03419-7","article-title":"Impact of suspected adverse drug reactions on mortality and length of hospital stay in the hospitalised patients: a meta-analysis","volume":"79","author":"Patel","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"2026081801401018000_10.1.e004745.15","doi-asserted-by":"crossref","DOI":"10.1177\/2325958218823208","article-title":"Prevalence of Adverse Drug Reactions among Pediatric Patients on Antiretroviral Therapy in Selected Hospitals in Eastern Ethiopia: 8-Year Retrospective Cross-Sectional Study","volume":"18","author":"Abdela","year":"2019","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2026081801401018000_10.1.e004745.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-023-03891-9","article-title":"Adverse drug events and contributing factors among pediatric cancer patients at Jimma University medical center, Southwest Ethiopia","volume":"23","author":"Tola","year":"2023","journal-title":"BMC Pediatr"},{"key":"2026081801401018000_10.1.e004745.17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/DHPS.S254644","article-title":"Chemotherapy-Related Adverse Drug Reaction and Associated Factors Among Hospitalized Paediatric Cancer Patients at Hospitals in North-West Ethiopia","volume":"12","author":"Workalemahu","year":"2020","journal-title":"Drug Healthc Patient Saf"},{"key":"2026081801401018000_10.1.e004745.18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12887-015-0401-0","article-title":"Adverse drug events in hospitalized children at Ethiopian University Hospital: a prospective observational study","volume":"15","author":"Eshetie","year":"2015","journal-title":"BMC Pediatr"},{"key":"2026081801401018000_10.1.e004745.19","unstructured":"Vandenbroucke JP , von Elm E , Altman DG , et al . Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration."},{"key":"2026081801401018000_10.1.e004745.20","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7992"},{"key":"2026081801401018000_10.1.e004745.21","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.73"},{"key":"2026081801401018000_10.1.e004745.22","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001259"},{"key":"2026081801401018000_10.1.e004745.23","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200225010-00001"},{"key":"2026081801401018000_10.1.e004745.24","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-237","article-title":"Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children \u2013 a prospective observational cohort study of 6,601 admissions","volume":"11","author":"Thiesen","year":"2013","journal-title":"BMC Med"},{"key":"2026081801401018000_10.1.e004745.25","unstructured":"Organization WH . Anatomic therapeutic chemical classification. 2024. Available: https:\/\/atcddd.fhi.no\/atc_ddd_index\/ [Accessed 09 Aug 2025]."},{"key":"2026081801401018000_10.1.e004745.26","unstructured":"Organization WH . International statistical classification of diseases and related health problems (ICD), 2022. Available: https:\/\/www.who.int\/standards\/classifications\/classification-of-diseases"},{"key":"2026081801401018000_10.1.e004745.27","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"2026081801401018000_10.1.e004745.28","unstructured":"Hartwig SC , Siegel J , Schneider PJ , et al . Preventability and severity assessment in reporting adverse drug reactions."},{"key":"2026081801401018000_10.1.e004745.29","unstructured":"Schumock GT , Thornton JP , Thornton JP . Focusing on the preventability of adverse drug reactions."},{"key":"2026081801401018000_10.1.e004745.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.16.2114"},{"key":"2026081801401018000_10.1.e004745.31","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.157.1.60"},{"key":"2026081801401018000_10.1.e004745.32","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200911020-00005"},{"key":"2026081801401018000_10.1.e004745.33","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-1779"},{"key":"2026081801401018000_10.1.e004745.34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pedn.2025.07.004","article-title":"Call for action: Adverse drug events and level of harm in hospitalized pediatric patients in Palestine: A retrospective cohort study","volume":"84","author":"Mattour","year":"2025","journal-title":"J Pediatr Nurs"},{"key":"2026081801401018000_10.1.e004745.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182327","article-title":"Risk factors for adverse drug reactions in pediatric inpatients: A cohort study","volume":"12","author":"Andrade","year":"2017","journal-title":"PLoS One"},{"key":"2026081801401018000_10.1.e004745.36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001868","article-title":"Adverse drug events in a paediatric intensive care unit: a prospective cohort","volume":"3","author":"Silva","year":"2013","journal-title":"BMJ Open"},{"key":"2026081801401018000_10.1.e004745.37","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1187"},{"key":"2026081801401018000_10.1.e004745.38","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932010-00002"},{"key":"2026081801401018000_10.1.e004745.39","doi-asserted-by":"crossref","unstructured":"Gupta S , Zaki SA , Masavkar S , et al . Causality, Severity, and Avoidability of Adverse Drug Reactions in Hospitalized Children: A Prospective Cohort Study. Cureus 2023;15. doi:10.7759\/cureus.33369","DOI":"10.7759\/cureus.33369"},{"key":"2026081801401018000_10.1.e004745.40","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12222"},{"key":"2026081801401018000_10.1.e004745.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-019-1892-x","article-title":"Serious adverse drug reactions at two children\u2019s hospitals in South Africa","volume":"20","author":"Mouton","year":"2020","journal-title":"BMC Pediatr"},{"key":"2026081801401018000_10.1.e004745.42","doi-asserted-by":"crossref","first-page":"949520","DOI":"10.3389\/fmed.2022.949520","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed\/MEDLINE case reports from 1980 to 2020","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med"},{"key":"2026081801401018000_10.1.e004745.43","doi-asserted-by":"crossref","first-page":"659099","DOI":"10.3389\/fphar.2021.659099","article-title":"Predicting Adverse Drug Events in Chinese Pediatric Inpatients With the Associated Risk Factors: A Machine Learning Study","volume":"12","author":"Yu","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026081801401018000_10.1.e004745.44","doi-asserted-by":"crossref","first-page":"698907","DOI":"10.3389\/fphar.2021.698907","article-title":"Drug-Related Problems of Patients in Primary Health Care Institutions: A Systematic Review","volume":"12","author":"Ni","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026081801401018000_10.1.e004745.45","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1070325","article-title":"Reduction in broad-spectrum antimicrobial prescriptions by primary care pediatricians following a multifaceted antimicrobial stewardship program","volume":"10","author":"Pagano","year":"2022","journal-title":"Front Pediatr"},{"key":"2026081801401018000_10.1.e004745.46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11096-020-01175-1","article-title":"Off-label antibiotic use among paediatric in-patients: a mixed-method prospective study at a tertiary hospital in southwestern Uganda","volume":"43","author":"Obura","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"2026081801401018000_10.1.e004745.47","unstructured":"Goodman LS . Goodman and gilman\u2019s the pharmacological basis of therapeutics. New York: McGraw-Hill, 1996."},{"key":"2026081801401018000_10.1.e004745.48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2019-000435","article-title":"Mild to moderate hypersensitivity reactions to beta-lactams in children: a single-centre retrospective review","volume":"3","author":"Vila","year":"2019","journal-title":"BMJ Paediatr Open"},{"key":"2026081801401018000_10.1.e004745.49","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1000","article-title":"Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures","volume":"143","author":"Cot\u00e9","year":"2019","journal-title":"Pediatrics"},{"key":"2026081801401018000_10.1.e004745.50","first-page":"821","article-title":"Polypharmacy in Children with Medical Complexity: A Cross-Sectional Study in a Pediatric Palliative Care Center","volume":"11","author":"Zanin","year":"2024","journal-title":"Children (Basel)"},{"key":"2026081801401018000_10.1.e004745.51","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/pds.4719","article-title":"Variation of the prevalence of pediatric polypharmacy: A scoping review","volume":"28","author":"Baker","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026081801401018000_10.1.e004745.52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.21111\/pharmasipha.v9i1.12614","article-title":"The relationship between polypharmacy and the incidence of drug interactions in pediatric inpatients at the regional general hospital (RSUD) Embung Fatimah Batam city","volume":"9","author":"Wahyudi","year":"2025","journal-title":"Pharmasipha"},{"key":"2026081801401018000_10.1.e004745.53","doi-asserted-by":"crossref","unstructured":"Moss J , Rashed A , Jensen J , et al . 25 point prevalence study of paediatric polypharmacy. BMJ Publishing Group Ltd, 2023.","DOI":"10.1136\/archdischild-2023-ESDPPP.25"},{"key":"2026081801401018000_10.1.e004745.54","doi-asserted-by":"crossref","first-page":"102391","DOI":"10.1016\/j.japh.2025.102391","article-title":"Challenges of managing pediatric polypharmacy in a pediatric complex care program: A qualitative pilot study","volume":"65","author":"Reedy","year":"2025","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2026081801401018000_10.1.e004745.55","article-title":"Polypharmacy in children hospitalized due to respiratory problems: data from a university hospital","volume":"52","author":"Gogou","year":"2018","journal-title":"Eur Resp J"},{"key":"2026081801401018000_10.1.e004745.56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/pediatric14020038","article-title":"A Prospective Study of Medication Surveillance of a Pediatric Tertiary Care Hospital in Lahore, Pakistan","volume":"14","author":"Nawaz","year":"2022","journal-title":"Pediatr Rep"},{"key":"2026081801401018000_10.1.e004745.57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"Davies","year":"2009","journal-title":"PLoS One"},{"key":"2026081801401018000_10.1.e004745.58","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10094"},{"key":"2026081801401018000_10.1.e004745.59","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.120957"},{"key":"2026081801401018000_10.1.e004745.60","doi-asserted-by":"publisher","DOI":"10.2165\/11599540-000000000-00000"},{"key":"2026081801401018000_10.1.e004745.61","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41397-018-0053-1","article-title":"Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults","volume":"19","author":"Chan","year":"2019","journal-title":"Pharmacogenomics J"},{"key":"2026081801401018000_10.1.e004745.62","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2018.1491547"}],"container-title":["BMJ Paediatrics Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjpo-2026-004745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:40:24Z","timestamp":1787042424000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpaedsopen.bmj.com\/lookup\/doi\/10.1136\/bmjpo-2026-004745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,8,18]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjpo-2026-004745"],"URL":"https:\/\/doi.org\/10.1136\/bmjpo-2026-004745","relation":{},"ISSN":["2399-9772"],"issn-type":[{"value":"2399-9772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}